Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate
- PMID: 3529085
- PMCID: PMC386527
- DOI: 10.1073/pnas.83.17.6480
Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate
Abstract
We have examined the role of the c-myc protooncogene in chemically induced differentiation of mouse erythroleukemia (MEL) cells by transfecting the cells with recombinant plasmids in which c-myc coding sequences were cloned downstream from the mouse metallothionein I promoter in sense and antisense orientations. We previously showed that treatment of MEL cells with inducers of differentiation leads to a rapid (less than 2 hr) decrease in the level of c-myc mRNA. c-myc mRNA is then transiently restored to pretreatment levels approximately 12-18 hr later. These events occur prior to the detection of cells that are irreversibly committed to erythroid differentiation. MEL cell transfectants containing the plasmid with myc in the sense orientation express a chimeric MT-myc mRNA, which also decreases shortly after addition of inducer. However, these clones reexpress myc RNA more rapidly than the parental line and they also differentiate more rapidly. On the other hand, transfectants containing the plasmid with myc in the antisense orientation exhibited a delay in the reexpression of c-myc mRNA and were found to differentiate more slowly than parental cells. Thus, we find a correlation between the time at which myc RNA is reexpressed following inducer treatment and the rate of entry of cells into the terminal differentiation program.
Similar articles
-
Contributions of transcriptional and post-transcriptional mechanisms to the regulation of c-myc expression in mouse erythroleukemia cells.Genes Dev. 1987 Nov;1(9):938-45. doi: 10.1101/gad.1.9.938. Genes Dev. 1987. PMID: 3480843
-
c-myc protooncogene expression in mouse erythroleukemia cells.Environ Health Perspect. 1989 Mar;80:161-72. doi: 10.1289/ehp.8980161. Environ Health Perspect. 1989. PMID: 2647476 Free PMC article. Review.
-
c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment.Proc Natl Acad Sci U S A. 1985 Aug;82(16):5323-7. doi: 10.1073/pnas.82.16.5323. Proc Natl Acad Sci U S A. 1985. PMID: 3860863 Free PMC article.
-
c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells.Mol Cell Biol. 1988 Sep;8(9):3683-95. doi: 10.1128/mcb.8.9.3683-3695.1988. Mol Cell Biol. 1988. PMID: 2464742 Free PMC article.
-
Induction of transformed cells to terminal differentiation.Ann N Y Acad Sci. 1987;511:246-55. doi: 10.1111/j.1749-6632.1987.tb36252.x. Ann N Y Acad Sci. 1987. PMID: 3326466 Review.
Cited by
-
Posttranscriptional regulation of cellular gene expression by the c-myc oncogene.Mol Cell Biol. 1989 Jan;9(1):124-34. doi: 10.1128/mcb.9.1.124-134.1989. Mol Cell Biol. 1989. PMID: 2467185 Free PMC article.
-
raf/myc-infected erythroid cells are restricted in their ability to terminally differentiate.J Virol. 1989 Mar;63(3):1489-92. doi: 10.1128/JVI.63.3.1489-1492.1989. J Virol. 1989. PMID: 2915388 Free PMC article.
-
Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy.Ther Adv Chronic Dis. 2011 Mar 1;2(2):133-44. doi: 10.1177/2040622310393059. Ther Adv Chronic Dis. 2011. PMID: 21858245 Free PMC article.
-
The c-myc proto-oncogene regulates cardiac development in transgenic mice.Mol Cell Biol. 1990 Jul;10(7):3709-16. doi: 10.1128/mcb.10.7.3709-3716.1990. Mol Cell Biol. 1990. PMID: 1694017 Free PMC article.
-
Dimethyl sulfoxide-inducible cytoplasmic factor involved in erythroid differentiation in mouse erythroleukemia (Friend) cells.Proc Natl Acad Sci U S A. 1987 Sep;84(18):6481-5. doi: 10.1073/pnas.84.18.6481. Proc Natl Acad Sci U S A. 1987. PMID: 3476957 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources